Federal Court Overseeing Testosterone Lawsuits Issues Order Pertaining to AndroGel Bellwether Trials, Bernstein Liebhard LLP Reports

Share Article

The Firm is evaluating testosterone treatment lawsuits on behalf of men who experienced serious cardiovascular problems, allegedly due to their use of AndroGel and other testosterone replacement medications.

Free Case Review
Our Firm has heard from many men who were allegedly injured by AndroGel and other testosterone treatments.

Testosterone lawsuits (http://www.testosteronelawsuithub.com/) filed against the manufacturers of AndroGel and other testosterone replacement medications continue to move forward in federal court, Bernstein Liebhard LLP reports. According to a Case Management Order issued in the U.S. District Court, Northern District of Illinois, on November 6, 2014, the Court has established a schedule governing bellwether trials for lawsuits filed against AbbVie, Inc., the manufacturer of AndroGel. Among other things, the order directs the parties to select a total of 16 AndroGel lawsuits as possible bellwether candidates by July 11, 2015. By March 1, 2016, the Court will choose six cases for the litigation’s first trials, and designate the order in which the cases will go to trial. The Order states that the first of the AndroGel trials will begin on October 31, 2016. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm has heard from many men who were allegedly injured by AndroGel and other testosterone treatments. We look forward to the commencement of bellwether trials in the federal litigation, as their outcomes may provide valuable insight into how juries will decide similar cases,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering testosterone lawsuit reviews to victims of heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other life-threatening heart problems that were allegedly caused by prescription testosterone medication.

Testosterone Litigation
Court documents indicate that more than 220 testosterone treatment lawsuits have been filed in the federal litigation underway in the Northern District of Illinois, where all federally-filed product liability claims involving these medications have been consolidated in a multidistrict litigation for coordinated pretrial proceedings. All of these cases similarly allege that the use of drugs like AndroGel increases a patient’s risk for life-threatening cardiovascular events, including heart attacks, strokes and blood clots. The lawsuits further allege that the manufacturers of testosterone therapies engaged in aggressive marketing that encouraged men without any real medical need to seek treatment for low sex drive, fatigue and other symptoms merely associated with aging.

The U.S. Food & Drug Administration (FDA) has been reviewing the safety of low testosterone therapy since January, after two studies suggested that testosterone replacement therapies might increase the likelihood of strokes, heart attack and death in older men, as well as those with pre-existing heart disease. In September, a panel of outside advisors convened by the FDA recommended that the manufacturers of the medications be required to conduct studies of their cardiovascular side effects. The advisors also recommended that the labeling for low testosterone therapies be revised to make clear they have not been shown to lessen symptoms commonly experienced by aging men.*

Men who allegedly suffered dangerous heart problems due to their use of AndroGel and other testosterone replacement drugs may be entitled to file their own testosterone lawsuit. To learn more about the ongoing testosterone litigation, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*reuters.com/article/2014/09/17/us-usa-health-testosterone-idUSKBN0HC2C320140917, Reuters, September 18, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.testosteronelawsuithub.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website